SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-057110
Filing Date
2008-03-14
Accepted
2008-03-14 14:16:36
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1089551
2 FORM OF COMMON STOCK CERTIFICATE dex41.htm EX-4.1 15158
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1905
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1730
5 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6717
6 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6747
7 STATEMENT OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 3040
8 STATEMENT OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 3040
9 GRAPHIC g94137g41s66.jpg GRAPHIC 41282
10 GRAPHIC g94137g89v90.jpg GRAPHIC 48454
11 GRAPHIC g94137img.jpg GRAPHIC 158599
  Complete submission text file 0001193125-08-057110.txt   1472094
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31141 | Film No.: 08688924
SIC: 2834 Pharmaceutical Preparations